(Q33347668)

26 July 2017

title

Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer (English)

1 reference

26 July 2017

Phase II Trial of the Use of Gemcitabine and 5-Fluorouracil in the Treatment of Advanced Pancreatic and Biliary Tract Cancer (English)

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

27 December 2023

main subject

phase II clinical trial

0 references

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

27 December 2023

author name string

Andre M. Murad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714886

27 December 2023

Rodrigo C. Guimarães

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714886

27 December 2023

Bruno C. Aragão

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714886

27 December 2023

Víctor H. Rodrigues

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714886

27 December 2023

Antonio O. Scalabrini-Neto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714886

27 December 2023

Charles A. J. Padua

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714886

27 December 2023

Flavio C. Moore

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714886

27 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12714886

27 December 2023

publication date

1 April 2003

1 reference

full work available at URL

26 July 2017

https://journals.lww.com/00000421-200304000-00010

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

American Journal of Clinical Oncology

27 December 2023

published in

1 reference

26 July 2017

volume

26

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

151-154

1 reference

26 July 2017

1

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

International Journal of Pancreatology

27 December 2023

2

7

209

Arbuck

1990

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study

27 December 2023

4

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

27 December 2023

5

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: a case report

27 December 2023

6

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

Nonparametric Estimation from Incomplete Observations

27 December 2023

8

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

27 December 2023

9

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

Current chemotherapeutic possibilities in pancreaticobiliary cancer

27 December 2023

10

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00010

27 December 2023

Identifiers

1 reference

26 July 2017

1 reference